MOXONIDINA MYLAN 0.4mg tablets medication leaflet

C02AC05 moxonidine • Cardiovascular system | Antiadrenergic agents, centrally acting | Imidazoline receptor agonists

Moxonidine is an antihypertensive medication used for the treatment of essential hypertension. It works by stimulating imidazoline receptors in the brainstem, leading to reduced sympathetic activity and, consequently, lower blood pressure.

The medication is taken orally, usually once daily, with the dose adjusted based on the patient's response. Common side effects include dry mouth, fatigue, dizziness, and drowsiness.

Moxonidine is contraindicated in patients with severe renal impairment, severe bradycardia, or hypersensitivity to the active substance. Its use also requires caution in patients with heart failure.

This medication is an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications.

General data about MOXONIDINA MYLAN 0.4mg

Substance: moxonidine

Date of last drug list: 01-07-2017

Commercial code: W60308002

Concentration: 0.4mg

Pharmaceutical form: tablets

Quantity: 28

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for moxonidine

0.2mg, 0.3mg, 0.4mg

Other substances similar to moxonidine